Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Canggang Railway Ltd
HKEX:2169
|
CN |
|
G
|
Givot Olam Oil Exploration LP (1993)
OTC:GOOXF
|
IL |
|
RPSG Ventures Ltd
NSE:RPSGVENT
|
IN |
|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
US |
|
Arts Optical International Holdings Ltd
HKEX:1120
|
HK |
|
Serverworks Co Ltd
TSE:4434
|
JP |
|
D
|
Daesung Hi Tech Co Ltd
KOSDAQ:129920
|
KR |
|
A
|
Anhui Golden Seed Winery Co Ltd
SSE:600199
|
CN |
|
O
|
Orange Tour Cultural Holding Ltd
HKEX:8627
|
CN |
|
JAKKS Pacific Inc
NASDAQ:JAKK
|
US |
|
V
|
Velesto Energy Bhd
KLSE:VELESTO
|
MY |
|
C
|
Cardinal Health Inc
XBER:CLH
|
US |
|
O
|
Oval Corp
TSE:7727
|
JP |
|
Himatsingka Seide Ltd
NSE:HIMATSEIDE
|
IN |
|
Anyang Iron and Steel Co Ltd
SSE:600569
|
CN |
|
Amagasa Co Ltd
TSE:3070
|
JP |
|
L
|
Lien Chang Electronic Enterprise Co Ltd
TWSE:2431
|
TW |
|
Adidas AG
XETRA:ADS
|
DE |
|
I
|
ImmunoGen Inc
XETRA:IMU
|
US |
|
R
|
Resilux NV
LSE:0FSN
|
BE |
Bellevue Life Sciences Acquisition Corp
Total Liabilities
Bellevue Life Sciences Acquisition Corp
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
|
Total Liabilities
$4.1m
|
CAGR 3-Years
134%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WP Carey Inc
NYSE:WPC
|
Total Liabilities
$9.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
AltC Acquisition Corp
NYSE:OKLO
|
Total Liabilities
$52.2m
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Total Liabilities
$119.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Total Liabilities
$16.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Total Liabilities
$40.2B
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bellevue Life Sciences Acquisition Corp
Glance View
Bellevue Life Sciences Acquisition Corp. operates as a blank check company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The firm has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm may pursue an acquisition opportunity in any business industry or sector. The firm intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The firm neither engaged in any operations nor generated any revenues.
See Also
What is Bellevue Life Sciences Acquisition Corp's Total Liabilities?
Total Liabilities
4.1m
USD
Based on the financial report for Dec 31, 2023, Bellevue Life Sciences Acquisition Corp's Total Liabilities amounts to 4.1m USD.
What is Bellevue Life Sciences Acquisition Corp's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
134%
Over the last year, the Total Liabilities growth was 226%. The average annual Total Liabilities growth rates for Bellevue Life Sciences Acquisition Corp have been 134% over the past three years .
